Korean Gynecologic Oncology Group

Total 158

Page 5 / 16

정렬순서

10개씩보기

Under development
gynecological cancer
(KGOG2027)

NRG-GY020: A PHASE III RANDOMIZED TRIAL OF RADIATION +/- MK-3475 (PEMBROLIZUMAB) FOR NEWLY DIAGNOSED EARLY STAGE HIGH INTERMEDIATE RISK MISMATCH REPAIR DEFICIENT (dMMR) ENDOMETRIOID ENDOMETRIAL CANCER
- PIJeong Yeol Park
- Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
- Current Enrollment / Estimated Enrollment 32 / 168 (19.0%)
Under development
gynecological cancer
(KGOG2025)

AtTEnd: Phase III Double-Blind Randomized Placebo Controlled Trial of Atezolizumab in Combination with Paclitaxel and Carboplatin in Women with Advanced/Recurrent Endometrial Cancer
- PIChul Min Lee
- Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
- Current Enrollment / Estimated Enrollment 550 / 550 (100.0%)
Under development
gynecological cancer
(KGOG2023)

Efficacy of adjuvant hormone therapy in patients with low or low-intermediate risk endometrial cancer combined by positive peritoneal cytology: a multicenter trial
- PIBanghyun Lee
- Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
- Current Enrollment / Estimated Enrollment 0 / 66 (0.0%)
Under development
gynecological cancer
(KGOG2022)

NRG-GY018: A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PEMBROLIZUMAB (MK-3475, NSC #776864) IN ADDITION TO PACLITAXEL AND CARBOPLATIN FOR MEASURABLE STAGE III OR IVA, STAGE IVB OR RECURRENT ENDOMETRIAL CANCER
- PIBeob-Jong Kim
- Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
- Current Enrollment / Estimated Enrollment 461 / 810 (56.89%)
Under development
gynecological cancer
(KGOG1046)

AFTER trial: Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer ; a phase 3 trial
- PISeung-Hyuk Shim
- Registration Date/ Last Update Posted 2022-05-10/ 2022-05-10
- Current Enrollment / Estimated Enrollment 0 / 50 (0.0%)
Under development
gynecological cancer
(KGOG1044)

Feasibility of HPV DNA and vaginal infectious disease detection in mail-delivered self obtained vaginal sample obtained by G+Kitⓡ (SELPAX-I)
- PIMoon-Hong Kim
- Registration Date/ Last Update Posted 2022-05-10/ 2022-05-10
- Current Enrollment / Estimated Enrollment 0 / 316 (0.0%)
Under development
gynecological cancer
(KGOG1039)

Impact of Metformin on Survival Outcome in Recurrent, Metastatic, and Persistent Cervical Cancer with Paclitaxel, Cisplatin, and Bevacizumab: Open Label Prospective Multicenter Randomized Control Trial
- PIMin-Hyun Baek
- Registration Date/ Last Update Posted 2022-05-10/ 2023-03-29
- Current Enrollment / Estimated Enrollment 0 / 0 (0.0%)
Under development
gynecological cancer
(KGOG3053)

NRG CC-008 clinical trial : A Non-Randomized Prospective Clinical Trail Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers (SOROC)
- PIHyun Jin Choi
- Registration Date/ Last Update Posted 2022-05-10/ 2025-04-18
- Current Enrollment / Estimated Enrollment 763 / 2262 (33.7%)
Closed
gynecological cancer
(KGOG1048)

Prediction model for survival and recurrence in early-stage cervical cancer patients with radical trachelectomy: A Multi-center Cohort Study (Korean Radical Trachelectomy of CX CA Assessment Study)
- PIDae-Yeon Kim
- Registration Date/ Last Update Posted 2023-03-14/ 2025-03-04
- Current Enrollment / Estimated Enrollment 306 / 400 (77.0%)
Closed
gynecological cancer
(KGOG2033)

Comparison of various progestin treatments in patients with atypical endometrial hyperplasia ? multicenter retrospective study (CoPIA)
- PIKidong Kim
- Registration Date/ Last Update Posted 2023-03-14/ 2024-09-04
- Current Enrollment / Estimated Enrollment 102 / 500 (20.4%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.

Under development gynecological cancer (KGOG2027)

NRG-GY020: A PHASE III RANDOMIZED TRIAL OF RADIATION +/- MK-3475 (PEMBROLIZUMAB) FOR NEWLY DIAGNOSED EARLY STAGE HIGH INTERMEDIATE RISK MISMATCH REPAIR DEFICIENT (dMMR) ENDOMETRIOID ENDOMETRIAL CANCER
- PI / PI기관 Jeong Yeol Park /
- Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
- Current Enrollment / Estimated Enrollment 32 person / 168 person (19.0%)
Under development gynecological cancer (KGOG2025)

AtTEnd: Phase III Double-Blind Randomized Placebo Controlled Trial of Atezolizumab in Combination with Paclitaxel and Carboplatin in Women with Advanced/Recurrent Endometrial Cancer
- PI / PI기관 Chul Min Lee /
- Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
- Current Enrollment / Estimated Enrollment 550 person / 550 person (100.0%)
Under development gynecological cancer (KGOG2023)

Efficacy of adjuvant hormone therapy in patients with low or low-intermediate risk endometrial cancer combined by positive peritoneal cytology: a multicenter trial
- PI / PI기관 Banghyun Lee /
- Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
- Current Enrollment / Estimated Enrollment 0 person / 66 person (0.0%)
Under development gynecological cancer (KGOG2022)

NRG-GY018: A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY OF PEMBROLIZUMAB (MK-3475, NSC #776864) IN ADDITION TO PACLITAXEL AND CARBOPLATIN FOR MEASURABLE STAGE III OR IVA, STAGE IVB OR RECURRENT ENDOMETRIAL CANCER
- PI / PI기관 Beob-Jong Kim /
- Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
- Current Enrollment / Estimated Enrollment 461 person / 810 person (56.89999999999999%)
Under development gynecological cancer (KGOG1046)

AFTER trial: Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer ; a phase 3 trial
- PI / PI기관 Seung-Hyuk Shim /
- Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
- Current Enrollment / Estimated Enrollment 0 person / 50 person (0.0%)
Under development gynecological cancer (KGOG1044)

Feasibility of HPV DNA and vaginal infectious disease detection in mail-delivered self obtained vaginal sample obtained by G+Kitⓡ (SELPAX-I)
- PI / PI기관 Moon-Hong Kim /
- Registration Date / Last Update Posted 2022-05-10 / 2022-05-10
- Current Enrollment / Estimated Enrollment 0 person / 316 person (0.0%)
Under development gynecological cancer (KGOG1039)

Impact of Metformin on Survival Outcome in Recurrent, Metastatic, and Persistent Cervical Cancer with Paclitaxel, Cisplatin, and Bevacizumab: Open Label Prospective Multicenter Randomized Control Trial
- PI / PI기관 Min-Hyun Baek /
- Registration Date / Last Update Posted 2022-05-10 / 2023-03-29
- Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)
Under development gynecological cancer (KGOG3053)

NRG CC-008 clinical trial : A Non-Randomized Prospective Clinical Trail Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers (SOROC)
- PI / PI기관 Hyun Jin Choi / Chung-Ang University Gwangmyeong Hospital()
- Registration Date / Last Update Posted 2022-05-10 / 2025-04-18
- Current Enrollment / Estimated Enrollment 763 person / 2262 person (33.7%)
Closed gynecological cancer (KGOG1048)

Prediction model for survival and recurrence in early-stage cervical cancer patients with radical trachelectomy: A Multi-center Cohort Study (Korean Radical Trachelectomy of CX CA Assessment Study)
- PI / PI기관 Dae-Yeon Kim / 서울아산병원(Asan Medical Center)()
- Registration Date / Last Update Posted 2023-03-14 / 2025-03-04
- Current Enrollment / Estimated Enrollment 306 person / 400 person (77.0%)
Closed gynecological cancer (KGOG2033)

Comparison of various progestin treatments in patients with atypical endometrial hyperplasia ? multicenter retrospective study (CoPIA)
- PI / PI기관 Kidong Kim / 분당서울대병원(Seoul National University Bundang Hospital)()
- Registration Date / Last Update Posted 2023-03-14 / 2024-09-04
- Current Enrollment / Estimated Enrollment 102 person / 500 person (20.4%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.

1 2 3 4 5 6 7 8 9 10

Logo

MENU

KGOG Clinical Trials Search